The incidence and prevalence of Crohn's disease (CD) is rising globally. Patients with
moderate to severe CD are at high risk for needing surgery and hospitalization and for …

Inflammatory bowel disease incidence has been constantly rising for the past few decades.
Current therapies attempt to mitigate its symptoms since no cure is established. The most …

Inflammatory bowel disease (IBD) is a chronic and relapsing immune‐mediated disease of
the gastrointestinal tract with a gradually increasing global incidence and prevalence. A …

BACKGROUND Medications for inflammatory bowel disease (IBD) have changed
dramatically over time. However, no study on long-term medication profiles has been …

Methods The Korean Association for the Study of Intestinal Diseases conducted a
multinational web-based survey for current IBD care in Asia between September 16, 2020 …

Background With the advent of biological therapy in IBD, it is uncertain to what extent
5aminosalicylates (5ASA) are used. Aims To explore whether or not 5ASA is continued once …

Abstract Background and Aims The benefit of continuing 5-aminosalicylic acid [5-ASA]
treatment when escalating to advanced therapies in patients with inflammatory bowel …

Abstract Background and Aims 5-aminosalicylates (5-ASA) are frequently used in the
management of Crohn's disease (CD). We used a de-identified administrative claims …

This thesis summarises the epidemiological research that I carried out from 2013 to 2021
during my employment at the Department of Surgery at Nordsjællands Hospital, the …

Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library Skip to
Article Content Skip to Article Information Wiley Online Library Wiley Online Library Search within …